{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-011748","form_type":"8-K","ticker":"CTKB","cik":"0001831915","company_name":"Cytek Biosciences, Inc.","filed_at":"2026-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.433788+00:00","generated_at":"2026-05-16T10:42:15.143970+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cytek sees Q4 rev $62M (+8% YoY); FY2025 rev ~$201M","bullets":["Preliminary Q4 2025 revenue of ~$62M, up 8% YoY and 19% QoQ.","Full-year 2025 revenue estimated at ~$201M.","CEO cites strong Services, Reagents and APAC instrument growth; EMEA returns to positive instrument sales.","Company to present at JP Morgan Healthcare Conference on Jan 14, 2026.","Full Q4 and FY results with 2026 guidance expected late February 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-011748","json":"https://secwatch.observer/filing/0001193125-26-011748.json","markdown":"https://secwatch.observer/filing/0001193125-26-011748.md","text":"https://secwatch.observer/filing/0001193125-26-011748.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831915/000119312526011748/0001193125-26-011748-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831915/000119312526011748/d41645d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:42:15.143970+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}